Stages Of Perimenopause: What To Expect At Every Phase

An estimated 2 million women in the U.S. enter perimenopause each year, and many are told their lab results look normal, even when symptoms suggest hormonal shifts that standard panels don't capture. But nothing feels normal. Sleep has changed. Cycles are unpredictable. Anxiety appears without a clear trigger. The stages of perimenopause don't follow a straight line, and routine lab work frequently misses the early hormonal changes behind those symptoms.

Marek Health offers in-depth hormone testing that goes well beyond what a standard annual physical covers. But before ordering any labs, identifying the correct stage of perimenopause matters more than most women realize. The stage shapes the symptoms, the hormone patterns, and the right course of action.

What Is Perimenopause?

Perimenopause is the transition period before menopause when the body's reproductive hormones begin shifting. It's sometimes called a "second puberty" because of how dramatically hormone levels can swing. Average onset falls in the mid-40s, though perimenopause can start as early as the mid-30s. Most women reach menopause (defined as 12 consecutive months without a period) around age 51 to 52 (Cleveland Clinic, 2024).

Perimenopause typically lasts about four years but can range from a few months to over eight years. During this time, the ovaries gradually produce less estrogen and progesterone, causing irregular cycles and symptoms like hot flashes, sleep disruption, and mood changes. Perimenopause is often when symptoms are most unpredictable, though for many women certain symptoms persist well into post-menopause.

The duration depends on genetics, lifestyle, and overall metabolic health. One note on scope: this article doesn't cover premature ovarian insufficiency or surgically induced menopause. Both follow different hormonal patterns and require separate evaluation.

The Four Stages of Perimenopause

The most widely referenced staging framework comes from research by Canadian endocrinologist Dr. Jerilynn Prior. It divides the transition into four phases based on menstrual cycle patterns and hormonal shifts. The STRAW+10 staging system, developed by a multi-society panel including the Endocrine Society and The Menopause Society, uses similar criteria (Harlow et al., 2012).

1. Very early perimenopause. Periods remain regular, but subtle hormonal changes have already begun.

2. Early menopause transition. Cycles become irregular, often varying by seven or more days.

3. Late menopause transition. At least one cycle stretches past 60 days. Periods get skipped regularly.

4. Late perimenopause. Periods have stopped, but 12 months haven't yet passed to confirm menopause.

Treating stage one the same as stage three is one of the most common mistakes in hormone health for women. Each stage calls for different labs and a different response.

How Do Symptoms Change Across the Stages of Perimenopause?

Most providers and clients assume estrogen decline drives early perimenopausal symptoms. It doesn't. Early symptoms may be driven in part by declining progesterone from more frequent anovulatory cycles, though the hormonal picture is complex and varies between individuals. Estrogen doesn't drop significantly until the later stages. In fact, estrogen levels spike and fluctuate unpredictably during early perimenopause, sometimes peaking well above pre-perimenopause levels in some women.

Common symptoms across all stages include heavier bleeding, shorter or longer cycle intervals, sleep disruption, mood shifts, hot flashes, night sweats, vaginal dryness, and new allergy-type reactions. Which symptoms dominate depends entirely on the stage a woman is in.

Between 60% and 80% of women experience vasomotor symptoms (hot flashes, night sweats) at some point during the menopausal transition, with prevalence varying by racial and ethnic group (Thurston & Joffe, 2011). The economic toll is real: a 2023 Mayo Clinic study estimated that menopause-related symptoms account for roughly $1.8 billion in lost work time per year in the U.S. alone (Faubion et al., 2023).

Hormonal Shifts During Each Stage

Stage 1: Very Early Perimenopause

Cycles may still arrive on schedule, but ovulation becomes sporadic. More anovulatory cycles (months where the body doesn't release an egg) mean less progesterone. Progesterone production depends largely on ovulation, so fewer ovulatory cycles generally mean less progesterone production over time.

Low progesterone at this stage may contribute to heavier periods, breast pain, and worsening PMS. Other symptoms like anxiety, sleep disruption, headaches, and histamine-related reactions are often multifactorial, with hormonal shifts being one of several possible contributors. Most standard panels miss this entirely because they don't test progesterone at all. A full hormone panel that includes progesterone (timed 5 to 7 days after ovulation) along with inflammation markers gives a much clearer picture of what's actually happening.

Stage 2: Early Menopause Transition

Cycles start varying by a week or more. Progesterone stays low while estrogen fluctuates wildly. When estrogen spikes high and then crashes, the drop feels steeper because it had further to fall. That's why hot flashes and night sweats may appear or worsen at this stage, even though estrogen isn't technically "low."

High fluctuating estrogen paired with low progesterone also raises questions about estrogen metabolism. When levels run high, the body needs to break estrogen down safely. Poor estrogen metabolism may amplify symptoms and may carry long-term health implications. Testing at this stage should evaluate estrogen levels, progesterone, and estrogen metabolite ratios. Providers offering personalized hormone therapy consider this stage a valuable window for baseline hormone and metabolic evaluation.

Symptoms at this stage frequently include heavy and painful periods, breast tenderness, irritability, histamine flares, hot flashes, vaginal dryness, abdominal weight gain, and disrupted sleep.

Stage 3: Late Menopause Transition

Periods start getting skipped entirely, with at least one cycle stretching past 60 days. Estrogen levels begin a real decline, though fluctuations may continue. Symptoms driven by high estrogen (breast pain, heavy bleeding) typically ease, while low-estrogen symptoms (hot flashes, vaginal dryness, joint pain, brain fog) become more prominent.

Falling hormones also tend to expose underlying metabolic issues. Insulin resistance may worsen as progesterone and estrogen drop. Abdominal weight gain may accelerate in part because shifting hormone ratios can contribute to a relative androgen excess in some women, which has been associated with worsening insulin sensitivity. Stress markers, inflammation panels, and metabolic testing become just as relevant as reproductive hormone levels at this point.

Stage 4: Late Perimenopause

Periods have likely stopped and ovulation has ceased, but the 12-month mark for menopause hasn't arrived yet. Estrogen is low and starting to stabilize. The mood swings and sleep disruption caused by earlier hormonal volatility may begin to ease, though hot flashes can persist for months or years beyond this stage.

Testing estrogen and progesterone can help confirm the stage, but the broader metabolic picture matters more now. Markers for stress, inflammation, and insulin resistance often tell a more useful story than reproductive hormones alone. Women who tracked their labs through previous stages with proactive monitoring tend to manage the transition to menopause with fewer surprises.

How Can Women Support Themselves Through Perimenopause?

Perimenopause support looks different for every woman, but two areas consistently matter regardless of stage. Lifestyle factors (sleep quality, nutrition, strength training, stress management) form the base. Beyond that, testing and, when appropriate, hormone therapy make the biggest difference.

Test Before Guessing

Testing during perimenopause can go well beyond estrogen. For some women, a broader panel that evaluates progesterone, estrogen metabolites, cortisol, thyroid markers, inflammatory markers, and insulin resistance may offer additional clinical context beyond what a basic check provides. Results, paired with symptom and cycle history, can help a provider build a more complete picture of where a woman is in the transition and what factors may be contributing to her symptoms.

Testing also matters before starting any form of hormone therapy. It can help guide initial decisions about which hormones may be appropriate, in what form, and at what starting dose, though dosing is typically adjusted based on symptom response over time. Marek Health offers hormone blood testing that connects results to a licensed provider's evaluation and a personalized protocol built around those findings.

Is Hormone Therapy the Right Move?

In early perimenopause, the problem is usually low progesterone, not low estrogen. Starting estrogen therapy during a stage when estrogen may already be running high can make symptoms worse. In many cases, the timing and hormone selection matter as much as the decision to use therapy. That said, hormone therapy carries individual risks that should be weighed against expected benefits.

Hormone therapy decisions should always involve shared decision-making between client and provider, accounting for personal health history, risk factors, and individual goals. Women with a history of certain conditions (including some cancers, blood clots, or active liver disease) may not be candidates for certain formulations.

In November 2025, the FDA began removing broad black box warnings from hormone replacement therapy products (FDA, 2025). Those warnings were based on a study of women averaging age 63 using a formulation no longer in common use. The updated labeling reflects current evidence and may help reduce the gap between symptom burden and treatment access.

Hormone therapy may be appropriate at multiple stages, but the protocol should shift as each phase progresses. Working with experienced health providers who adjust protocols based on labs and symptoms can support better management over time. The stages of perimenopause demand different responses at every turn. Lab work can inform the clinical picture, but perimenopause management always starts with a thorough symptom and menstrual history evaluation by a licensed provider.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

How long does perimenopause last? 

Perimenopause lasts a median of about four years, though it can range from a few months to over eight years. Duration depends on genetics, lifestyle, and metabolic health. It often starts in the mid-40s, but some women experience onset in their mid-30s.

What are the four stages of perimenopause? 

The four stages are very early perimenopause (regular periods with subtle hormonal changes), early menopause transition (irregular cycles varying by 7+ days), late menopause transition (cycles longer than 60 days), and late perimenopause (periods have stopped but 12 months haven't passed). This model follows the work of Dr. Jerilynn Prior and the STRAW+10 system used by the Endocrine Society.

Can perimenopause start in the 30s? 

Yes. Perimenopause can begin 8 to 10 years before menopause. Since the average age of menopause is 51 to 52, onset in the late 30s is possible and not rare. Early symptoms like worsening PMS, sleep disruption, or changes in cycle length may be the first indicators.

What is the first sign of perimenopause? 

For many women, the first signs are changes in cycle length or worsening PMS. Anxiety, breast tenderness, and heavier periods driven by declining progesterone often appear before estrogen-related symptoms like hot flashes. These early shifts are frequently missed by standard blood work.

Does perimenopause cause weight gain? 

Perimenopause may contribute to weight gain, especially around the abdomen. Declining progesterone and estrogen can worsen insulin resistance, and a relative excess of androgens may drive additional fat storage in the midsection. A 2023 Mayo Clinic study found that 13% of employed women reported at least one adverse work outcome tied to menopause symptoms, with more severe symptoms strongly predicting greater work disruption.

Should women get hormone testing during the stages of perimenopause? 

Testing may provide additional context alongside symptom and cycle history when evaluating where a woman is in the perimenopause transition. It can also help identify whether factors like stress, thyroid dysfunction, or poor estrogen metabolism are contributing to symptoms. Testing is recommended before starting any hormone therapy to help guide initial decisions about formulation and dosing.

Did the FDA change HRT warnings in 2025? 

In November 2025, the FDA began removing broad black box warnings from hormone replacement therapy products. The original warnings were based on a study of women averaging age 63 using a formulation no longer commonly prescribed. The updated labeling better reflects current evidence about HRT benefits and risks for women closer to the age of menopause.

References

• Cleveland Clinic. Perimenopause. Updated July 2024

• Climacteric. 2012;15(2):105–114

• Obstet Gynecol Clin North Am. 2011;38(3):489–501

• Mayo Clin Proc. 2023;98(6):833–845

• FDA Press Release. November 10, 2025